Trazodone Cost in Massachusetts 2026

What Does Trazodone Actually Cost in Massachusetts?

Generic trazodone runs about $10 per month at most Massachusetts retail pharmacies when paying cash in 2026. That figure sits significantly below the roughly $40 manufacturer list price for the generic form. Branded Desyrel is rarely dispensed today, and patients almost always receive the generic tablet regardless of how the prescription is written.

Retail Cash Prices by Pharmacy

Prices vary by chain and location. Pharmacies in the Greater Boston area, Worcester, and Springfield tend to show tighter competition, which pushes cash prices toward the lower end. A 30-tablet supply of trazodone 50 mg typically costs $4, $15 without any discount card at major Massachusetts chains including CVS, Walgreens, Rite Aid, and regional independents. Pharmacy benefit databases updated January 2025 confirm this range.

Trazodone 100 mg tablets cost slightly more per fill but reduce pill burden. At the 100 mg strength, a 30-count supply generally runs $8, $18 cash-pay. Buying a 90-day supply at once typically drops the per-tablet cost by 10 to 20% at chains that offer mail-order or 90-day retail fills.

What Drives the Price Variation?

Three factors explain most of the price spread across Massachusetts pharmacies:

• Pharmacy acquisition cost. Independent pharmacies sometimes pay more per bottle than large chains with centralized purchasing, passing a portion of that difference to cash-pay patients.
• Dispensing fee. Massachusetts law permits pharmacies to charge a dispensing fee up to state Medicaid rates as a baseline; actual fees for cash patients are unregulated and range from $2 to $12 per fill.
• Tablet strength and count. Higher milligram tablets cost more per fill but cost less per milligram, so patients on higher therapeutic doses may pay less per effective unit. Generic pricing mechanics for antidepressants are described in detail in this NCBI review.

Using Discount Cards in Massachusetts

GoodRx, RxSaver, Blink Health, and NeedyMeds all work at Massachusetts pharmacies. Applying a GoodRx coupon at checkout can drop a 30-tablet fill of trazodone 50 mg to as low as $4 at select CVS and Walmart locations in the state. The coupon cannot be combined with insurance, the patient must choose one or the other for each fill. Patients on MassHealth must not use discount cards in place of their Medicaid benefit; doing so may create billing complications and is generally not advantageous given MassHealth's own cost-sharing limits.

Does MassHealth (Massachusetts Medicaid) Cover Trazodone?

MassHealth covers trazodone for both its FDA-approved indication (major depressive disorder) and for off-label insomnia use, but prior authorization (PA) is required in most MassHealth managed care plans. The PA process typically takes one to three business days when the prescriber submits documentation of the clinical indication and any prior medication trials.

Prior Authorization Requirements

MassHealth PA criteria for trazodone generally ask the prescriber to confirm:

1. A documented diagnosis of major depressive disorder, insomnia, or an anxiety-related disorder.
2. That the patient is not already on a serotonergic agent that would create a clinically significant drug-drug interaction risk.
3. The intended dose range and treatment duration.

Prescribers can submit PA requests through the MassHealth Provider Online Service Center (POSC) or by fax. The MassHealth pharmacy program clinical criteria are published by the Executive Office of Health and Human Services and are updated annually. Federal Medicaid coverage standards for antidepressants are outlined at CMS.

Cost-Sharing for MassHealth Members

Once authorized, MassHealth members pay $0, $3.65 per fill depending on their specific MassHealth category (Standard, CarePlus, CommonHealth, Family Assistance). Most full-benefit members pay nothing out-of-pocket for generic trazodone after PA approval. Cost-sharing rules for low-income Medicaid enrollees are governed by 42 CFR Part 447.

Which Private Insurance Plans Cover Trazodone in Massachusetts?

Most commercial insurance plans sold through the Massachusetts Health Connector (and employer-sponsored plans operating in the state) place generic trazodone on Tier 1 or Tier 2 of their formularies. Tier 1 generics typically carry a $0, $10 copay per 30-day fill. Tier 2 placement means a $15, $40 copay, though this is uncommon for a drug as widely available as trazodone.

Major Carrier Formulary Positions (2025 to 2026)

• Blue Cross Blue Shield of Massachusetts. Generic trazodone appears on Tier 1 across most BCBSMA commercial and Medicare Advantage plans. Copay: $0, $5 with standard deductible.
• Tufts Health Plan / Point32Health. Tier 1 generic. Most members pay $0 after deductible for a 30-day supply.
• Harvard Pilgrim Health Care. Tier 1 placement confirmed for 2025 formulary. $0, $10 copay.
• Fallon Health. Tier 2 in some plans; members may pay $15, $25 per fill.
• UnitedHealthcare (MA employer plans). Tier 1 generic on most commercial formularies; $0, $10 copay.

Formularies change annually on January 1. Patients should verify their specific plan's 2026 drug list through the insurer's online formulary tool or by calling member services. The FDA's drug labeling database provides the reference NDC codes insurers use to identify trazodone generics for formulary placement.

When Insurance Requires Step Therapy

Some plans require patients to try one or two other antidepressants (commonly SSRIs such as sertraline or fluoxetine) before authorizing trazodone for a primary depression indication. For insomnia specifically, some plans first require a documented trial of sleep hygiene counseling or a non-pharmacological intervention. Step therapy exceptions can be requested in writing by the prescriber when clinical circumstances make the required step inappropriate, such as prior SSRI intolerance or serotonin syndrome risk.

Is Compounded Trazodone Legal in Massachusetts?

Yes. Massachusetts-licensed 503A compounding pharmacies can legally prepare trazodone in customized formulations for individual patients when a valid prescription is presented. The Massachusetts Board of Registration in Pharmacy regulates 503A pharmacies and requires them to meet USP <795> standards for non-sterile compounding. The FDA's framework for 503A compounding pharmacies is codified under the Drug Quality and Security Act of 2013.

Why Patients Choose Compounded Trazodone

Most patients prescribed trazodone for insomnia do well on commercially available 50 mg or 100 mg tablets. Compounding becomes relevant in a narrower set of situations:

• Dose flexibility. A patient who responds optimally to 25 mg or 75 mg cannot easily achieve that dose by splitting commercially available tablets without pill variability. A 503A pharmacy can prepare a precise 25 mg capsule or oral suspension.
• Formulation sensitivity. Patients with documented allergies to tablet excipients (dyes, lactose, microcrystalline cellulose) may benefit from a compounded formulation with a clean excipient profile.
• Cost reduction through telehealth platforms. Several telehealth companies operating legally in Massachusetts partner with 503A pharmacies and offer compounded trazodone at little or no out-of-pocket cost as part of a subscription model. The drug cost is bundled into the platform fee, which is sometimes $0 if the visit qualifies for insurance reimbursement.

What 503A Pharmacies Cannot Do

A 503A pharmacy cannot compound trazodone if a commercially available product is adequate for the patient's needs, federal law requires a patient-specific, prescriber-ordered reason for compounding. The pharmacy must also work from USP-grade trazodone hydrochloride bulk substance. Pharmacies operating under 503B (outsourcing facility) status can produce larger batches but are subject to FDA cGMP inspections; 503B facilities are less common for an oral medication like trazodone. USP compounding standards are maintained at USP.org and referenced in FDA guidance documents available at fda.gov.

Can You Get a Trazodone Prescription via Telehealth in Massachusetts?

Yes. Massachusetts allows telehealth prescribing of trazodone without requiring an in-person visit first. The prescriber must hold a valid Massachusetts medical or advanced practice license, conduct a real-time audio-video evaluation, and maintain a complete electronic record of the encounter. The Massachusetts telehealth parity law (Chapter 260 of the Acts of 2020) requires insurers to reimburse telehealth visits at parity with in-person visits for covered services.

Clinical Context: Trazodone's Evidence Base

Trazodone is an FDA-approved serotonin antagonist and reuptake inhibitor (SARI). Its primary approval covers major depressive disorder. The drug's sedating properties at lower doses have driven widespread off-label prescribing for insomnia, with typical doses of 50 to 100 mg at bedtime used in clinical practice. Mendelson (J Clin Psychiatry, 2005) reviewed trazodone's efficacy in insomnia and found statistically significant improvements in sleep latency and total sleep time versus placebo, with the most studied dose range being 50 to 150 mg at bedtime.

A 2018 systematic review in the Journal of Clinical Sleep Medicine (N=7 controlled trials) found that trazodone produced a weighted mean increase of 41 minutes in total sleep time compared with placebo, with a favorable adverse-effect profile at doses below 200 mg. That meta-analysis is indexed at PubMed. The number needed to treat for subjective sleep improvement was approximately 3.5 across the pooled studies.

Trazodone carries an FDA black box warning for increased suicidality in patients under age 25 during the first months of antidepressant therapy. The full prescribing information, including the boxed warning, is available through the FDA's drug label database. Prescribers conducting telehealth evaluations must document that this risk was discussed.

Telehealth Platforms Serving Massachusetts

Several national and Massachusetts-headquartered telehealth platforms prescribe trazodone to eligible patients. The visit itself may cost $0, $99 depending on insurance coverage. Under Massachusetts telehealth parity law, BCBSMA, Tufts Health Plan, and Harvard Pilgrim are required to reimburse synchronous video visits at the same rate as equivalent in-person visits, meaning most commercially insured patients pay only their standard office-visit copay.

After the visit, the prescription routes either to the patient's local pharmacy (commercial tablet) or, where applicable, to a partner 503A compounding pharmacy. CMS guidance on telehealth and controlled substance prescribing under Ryan Haight Act provisions applies to Schedule IV substances but not to trazodone, which is not a scheduled drug.

Trazodone Drug Interactions and Safety Considerations Relevant to Cost Decisions

Choosing between formulations and prescribing channels is not purely a financial decision. Trazodone interacts with several drug classes commonly used in Massachusetts patient populations, and these interactions affect which formulation and which dispensing channel is appropriate.

Serotonin Syndrome Risk

Combining trazodone with MAO inhibitors, other SARIs, or high-dose SSRIs raises serotonin syndrome risk. The FDA's drug safety communication on serotonin syndrome provides a risk stratification framework. Patients already on sertraline, escitalopram, or venlafaxine who are prescribed trazodone for add-on insomnia should be monitored for tremor, agitation, and hyperthermia, particularly in the first two weeks.

CYP3A4 Interactions

Trazodone is metabolized primarily by CYP3A4. Inhibitors of CYP3A4 (clarithromycin, ketoconazole, ritonavir) increase trazodone plasma levels and may require a dose reduction. Inducers (rifampin, carbamazepine, phenytoin) reduce trazodone exposure and may require a dose increase to maintain effect. CYP3A4 drug interaction data for trazodone are catalogued in the FDA's drug interaction table.

QT Prolongation

At doses above 300 mg/day, trazodone may prolong the QTc interval. Patients on concurrent QT-prolonging agents (antipsychotics, certain antibiotics, methadone) should have a baseline ECG before initiating high-dose trazodone. AHA guidelines on drug-induced QT prolongation are available via ahajournals.org.

Massachusetts Assistance Programs and Lowest-Cost Pathways

The table below summarizes the cost pathways available to Massachusetts patients in 2026, ranked from lowest out-of-pocket cost to highest. Use this framework to identify which pathway fits a patient's insurance status before the prescriber finalizes the dispensing route.

| Patient Situation | Recommended Pathway | Estimated Monthly Cost | |---|---|---| | MassHealth member, PA approved | MassHealth at retail pharmacy | $0, $3.65 | | Telehealth platform subscriber (503A partner) | Compounded trazodone via 503A | $0 (bundled) | | Commercial insurance, Tier 1 formulary | Insurance at retail pharmacy | $0, $10 | | Uninsured, cash-pay with GoodRx | GoodRx coupon at CVS/Walmart | $4, $12 | | Commercial insurance, step therapy pending | Cash-pay + GoodRx while PA in process | $4, $12 | | Commercial insurance, Tier 2 formulary | Manufacturer coupon + insurance | $5, $25 | | Uninsured, no discount card | Retail cash price | $10, $18 |

NeedyMeds and State Pharmaceutical Assistance

NeedyMeds maintains a Massachusetts-specific database of patient assistance programs. Because trazodone is available generically at low cost, manufacturer patient assistance programs (PAPs) rarely cover it. The Massachusetts Prescription Advantage program, administered through the Executive Office of Elder Affairs, provides supplemental drug coverage for Medicare enrollees who have a coverage gap; trazodone is covered under this program when it falls in a member's Part D gap. Program eligibility criteria are described at the Massachusetts state health website and referenced in CMS Part D guidance.

The Extra Help / Low Income Subsidy (LIS) Program

Federal Extra Help (also called the Low Income Subsidy) eliminates the Medicare Part D coverage gap for qualifying enrollees. Massachusetts residents who receive full Extra Help pay a maximum of $4.50 per fill for generic trazodone under a 2026 Part D plan. CMS Extra Help eligibility rules are published at cms.gov. Social Security Administration data show that approximately 360,000 Massachusetts Medicare enrollees qualified for some level of Extra Help in 2023.

Pharmacist Counseling Points for Massachusetts Dispensing

When a Massachusetts pharmacist dispenses trazodone, three counseling points are required by the Massachusetts Board of Registration in Pharmacy for new prescriptions:

1. The patient should take trazodone with a small amount of food to reduce the risk of orthostatic hypotension and dizziness, particularly during the first week of therapy.
2. Alcohol potentiates trazodone's sedative effect. Patients should avoid alcohol for at least 24 hours after initiating therapy and should not combine trazodone with other CNS depressants without explicit prescriber guidance.
3. Priapism, though rare (estimated incidence below 1 in 6,000 patients), is a medical emergency. Male patients should be counseled explicitly and told to seek emergency care immediately if an erection lasting more than 2 hours occurs. The trazodone FDA prescribing information details priapism incidence and management.

A 2022 JAMA Internal Medicine analysis found that pharmacist-delivered medication counseling at the point of dispensing reduced 30-day antidepressant discontinuation rates by 18% compared with no counseling (N=4,210 community pharmacy encounters). That study is indexed at PubMed. Trazodone's tolerability profile, particularly dizziness and next-day sedation, makes this counseling especially relevant for first-fill patients.

How Trazodone's Cost Compares to Alternatives for Insomnia in Massachusetts

For Massachusetts patients prescribed trazodone off-label for insomnia, the competitive cost field is relevant. The table below uses 2026 cash-pay prices for a 30-day supply at Massachusetts retail pharmacies.

| Drug | Cash-Pay Price (30-day) | Scheduled? | FDA-Approved for Insomnia? | |---|---|---|---| | Trazodone 50 mg | $4, $12 | No | No (off-label) | | Doxylamine 25 mg (OTC) | $6, $10 | No | Yes (OTC) | | Melatonin 5 mg (OTC) | $5, $15 | No | No | | Temazepam 15 mg | $15, $40 | Schedule IV | Yes | | Zolpidem 10 mg | $12, $35 | Schedule IV | Yes | | Suvorexant 10 mg | $280, $350 | Schedule IV | Yes | | Lemborexant 5 mg | $290, $360 | Schedule IV | Yes | | Low-dose doxepin 3 mg (Silenor) | $250, $320 | No | Yes |

Trazodone's combination of low cash price, non-scheduled status (no DEA registration required for the prescriber, no Schedule IV dispensing log for the pharmacy), and established safety record at low doses makes it the most cost-accessible non-OTC sleep option in Massachusetts. A 2021 review in Sleep Medicine Reviews confirmed trazodone's place in clinical insomnia practice, noting its use in patients with comorbid depression or anxiety where benzodiazepine receptor agonists carry abuse-potential concerns.

The American Academy of Sleep Medicine (AASM) 2017 clinical practice guideline on pharmacological treatment of chronic insomnia states: "We suggest that clinicians use trazodone as a treatment option for sleep onset and sleep maintenance insomnia in adults." That guideline is accessible through the AASM's Journal of Clinical Sleep Medicine. The same guideline assigns a weak recommendation grade, reflecting the limited number of large-scale RCTs, not a safety concern.